Microneedles deliver vital vaccines
Israel’s NanoPass Technologies is supplying its MicronJet600 microneedle system to US-based Immune Design who will use the system to deliver vaccines to cancer immunotherapy patients.
Israel ranks 6th in Healthy Life Expectancy
The World Health Organization (WHO) ranks Israel 6th in the world, with the average Israeli living without a terminal illness to age 71.5. Israeli men have the world’s fourth longest total life expectancy of 80.2 years. For women, Israel is ranked tenth with a total life expectancy of 84 years.
IBM Haifa’s diagnostic apps
More about the app developed by IBM Haifa to diagnose ADHD sufferers . It won top prize at the Brain Inspired Technology for Education (BITE) Hackathon at Israel’s Technion Institute. Also describes IBM Haifa’s dementia early-detection app .
Slowing down aggressive brain cancer
Israel’s Novocure was featured recently on ABC 10 News, which showed Novocure’s TTFields helmet being used to keep a San Diego brain cancer sufferer alive. Novocure is soon to trial TTFields on other solid cancers and has just filed for an IPO to raise up to $300 million.
Israeli device warns of risk to liver
I featured the “liver-on-a-chip” testing device invented by Hebrew University of Jerusalem scientists in a previous newsletter. The device has now shown that acetaminophen (a readily-available pain relief) can be toxic at far lower doses than previously thought.
Huntington’s treatment gets go ahead
The US FDA has approved the application by Israel’s Teva for its SD-809 (deutetrabenazine) treatment for Huntington’s disease. SD-809 was part of Teva’s May acquisition of Auspex and has completed two Phase-III studies.
Glaucoma treatment goes global
Israel’s BioLight has announced the first sale of XLVision Sciences’ IOPtiMate to a medical center in Peru. The innovative CO2 laser system has previously been purchased by hospitals in Hong Kong, Poland, Hungary and Romania.
MDA training for Israeli-Arab sector
Israel’s emergency services Magen David Adom has completed its first training course for 15 young medics who will provide emergency response to Eastern Jerusalem. The medics are bilingual in Hebrew and Arabic. The program was the initiative of Ziad Jadla, MDA’s Arab liaison.
Exercise to cure fatty liver disease
Nonalcoholic steatohepatitis (NASH) commonly known as “fatty liver disease” is the most common liver condition in the Western world. A study by Israeli doctors showed that 40 minutes resistance training, three times a week for three months reduced liver-fat and cholesterol significantly.
An app to detect ADHD
Researchers at IBM Israel have developed a prototype app that can detect attention deficit hyperactivity disorder (ADHD) symptoms. Subjects trace an imaginary rectangle ten times and the app analyzes the hand movements. ADHD sufferers have difficulty with continuous motor activity.